Bausch & Lomb (BLCO) Cash from Investing Activities (2021 - 2026)

Bausch & Lomb (BLCO) reported Cash from Investing Activities of -$130.0 million for Q1 2026, down 12.07% on a YoY basis from -$147.8 million in Q1 2025, and up 30.85% quarter-over-quarter from -$188.0 million in Q4 2025.

Bausch & Lomb (BLCO) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Bausch & Lomb has reported Cash from Investing Activities for 6 years, with the latest figure at -$130.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 12.07% year-over-year to -$130.0 million; the trailing twelve-month figure through Mar 2026 stood at -$469.0 million (changed 0.42% YoY), and the FY2025 full-year result was -$455.0 million, down 10.44% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$130.0 million, up from -$188.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$28.0 million in Q2 2023, with the low at -$1.9 billion in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$195.4 million across 5 years, with a median of -$90.0 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities sank 3740.82% — and 2024, when it surged 94.9%.
  • Bausch & Lomb's Cash from Investing Activities stood at -$90.0 million in 2022, then slumped by 50.0% to -$135.0 million in 2023, then slumped by 37.04% to -$185.0 million in 2024, then decreased by 1.62% to -$188.0 million in 2025, then soared by 30.85% to -$130.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$130.0 million (Q1 2026), -$188.0 million (Q4 2025), and -$61.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -139.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -96.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -58.03 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -42.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -77.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -90.00 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -131.58 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -133.00 Mn
10 Bausch & Lomb 5.32 Bn 5.12 Bn 973.00 Mn -130.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -130.00 Mn
Mar 31, 2026 -130.00 Mn
Dec 31, 2025 -188.00 Mn
Dec 31, 2025 -188.00 Mn
Sep 30, 2025 -61.00 Mn
Sep 30, 2025 -61.00 Mn
Jun 30, 2025 -90.00 Mn
Jun 30, 2025 -90.00 Mn
Mar 31, 2025 -116.00 Mn
Mar 31, 2025 -116.00 Mn
Dec 31, 2024 -185.00 Mn
Dec 31, 2024 -185.00 Mn
Sep 30, 2024 -96.00 Mn
Sep 30, 2024 -96.00 Mn
Jun 30, 2024 -74.00 Mn
Jun 30, 2024 -74.00 Mn
Mar 31, 2024 -57.00 Mn
Mar 31, 2024 -57.00 Mn
Dec 31, 2023 -135.00 Mn
Dec 31, 2023 -135.00 Mn